Researchers from Memorial Sloan-Kettering Cancer in NYC note that secondary testing with biomarkers and MRIs can help 40-50% of us avoid biopsies.
Share this post
MSK researchers offer primer on PSA, provide…
Share this post
Researchers from Memorial Sloan-Kettering Cancer in NYC note that secondary testing with biomarkers and MRIs can help 40-50% of us avoid biopsies.